The following categories are used to indicate the frequency of occurrence of adverse effects: Very common (≥1/10); Common (≥1/100 to <1/10); Uncommon (≥1/1,000 to <1/100); Rare ( 1/10,000 to <1/1,000); Very rare (<1/10,000); Unknown (Frequency not assessable based on the available data).
They are presented in the table as follows: See table.

Swelling face (unknown frequency) has been reported during post-marketing surveillance.
View ADR Reporting Link